Free shipping on all orders over $ 500

Cevipabulin

Cat. No. M4975

All AbMole products are for research use only, cannot be used for human consumption.

Cevipabulin Structure
Synonym:

TTI-237

Size Price Availability Quantity
10mM*1mL in DMSO USD 115  USD115 In stock
5mg USD 120  USD120 In stock
10mg USD 200  USD200 In stock
50mg USD 680  USD680 In stock
100mg USD 960  USD960 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Cevipabulin (TTI-237) is a novel, potent, oral, microtubule-active antitumor small molecule, inhibits the binding of [3H] vinblastine to tubulin, with an IC50 of 18-40 nM for cytotoxicity in human tumor cell line. Cevipabulin (TTI-237) inhibited the binding of [(3)H]vinblastine to tubulin, but it caused a marked increase in turbidity development that more closely resembled the effect observed with docetaxel than that observed with vincristine. Cevipabulin (TTI-237) was active in vivo in several nude mouse xenograft models of human cancer, including LoVo human colon carcinoma and U87-MG human glioblastoma, when dosed i.v. or p.o.

Chemical Information
Molecular Weight 464.82
Formula C18H18ClF5N6O
CAS Number 849550-05-6
Solubility (25°C) DMSO 15 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Beyer CF,et.al. Cancer Res TTI-237: a novel microtubule-active compound with in vivo antitumor activity.

Related Microtubule Products
Nab-Paclitaxel

Nab-Paclitaxel (Nanoparticle albumin-bound Paclitaxel) is an albumin-bound nanoparticle formulation of Paclitaxel. Nab-Paclitaxel is composed of albumin and the active pharmaceutical ingredient Paclitaxel, in which human albumin is used as an excipient to disperse and stabilize particles and carry the main drug. Nab-Paclitaxel is a solvent-free taxane with higher response rates and improved tolerability. Nab-Paclitaxel displays less toxicity and greater antitumor activity.

CCB02

CCB02 is a selective CPAP-tubulin interaction inhibitor, binding to tubulin and competing for the CPAP binding site of β-tubulin, with an IC50 of 689 nM, and shows potent anti-tumor activity.

Lisavanbulin

Lisavanbulin (BAL-101553) is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

20-O-Demethyl-AP3 

20-O-Demethyl-AP3 is a minor metabolite of Ansamitocin P-3.

Lisavanbulin dihydrochloride

Lisavanbulin (BAL-101553) dihydrochloride is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

  Catalog
Abmole Inhibitor Catalog




Keywords: Cevipabulin, TTI-237 supplier, Microtubule, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.